Neuphoria Therapeutics (NEUP) Q4 2024 Earnings Report

301 Followers

NEUP Q4 2024 EPS Results

Actual EPS-$0.95

Consensus EPS-$0.95

Beat/MissMet expectations

One Year Ago EPS-$1.06

Actual Revenue―

Expected Revenue$1.77M

Beat/Miss―

YoY Revenue Growth―

QuarterQ4 2024

Date08/21/2024

TimeTBA

Conference CallWednesday, August 21, 2024

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Sep 29, 2025	2025 (Q4)	-2.08 / -2.63	-29.208	91.00% (+26.58)
Feb 20, 2025	2025 (Q2)	- / -	―	―
Aug 21, 2024	2024 (Q4)	-0.95 / -0.95	-1.056	10.23% (+0.11)
Feb 22, 2024	2024 (Q2)	- / -1.06	-1.47	28.10% (+0.41)
Aug 23, 2023	2023 (Q4)	-1.12 / -	-1.153	―
Feb 23, 2023	2023 (Q2)	-7.97 / -17.64	-6.12	-188.32% (-11.52)
Aug 25, 2022	2022 (Q4)	-1166.40 / -13.84	-0.009	-153677.78% (-13.83)
Feb 22, 2022	2022 (Q2)	-12.29 / -6.12	0	―
Aug 25, 2021	2021 (Q4)	0.00 / >-0.01	0	―
Feb 26, 2021	2021 (Q2)	0.00 / 0.00	-1.112	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed